The latest closing stock price for Denali Therapeutics as of September 18, 2024 is 30.76.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $434 today, roughly 0 times their original investment - a 5.28% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 32.13, which is 4.5% above the current share price.
The Denali Therapeutics 52-week low stock price is 14.56, which is 52.7% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 20.40.
An investor who bought $1,000 worth of Denali Therapeutics stock at the IPO in 2017 would have $434 today, roughly 0 times their original investment - a 5.28% compound annual growth rate over 7 years.
The all-time high Denali Therapeutics stock closing price was 93.56 on December 22, 2020.
The Denali Therapeutics 52-week high stock price is 32.13, which is 4.5% above the current share price.
The Denali Therapeutics 52-week low stock price is 14.56, which is 52.7% below the current share price.
The average Denali Therapeutics stock price for the last 52 weeks is 20.40.